TrialInternational journal of radiation oncology, biology, physics2020

Phase 2 Trial of Neoadjuvant FOLFIRINOX and Intensity Modulated Radiation Therapy Concurrent With Fixed-Dose Rate-Gemcitabine in Patients With Borderline Resectable Pancreatic Cancer.

Nguyen H Tran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.